research and development

Showing 15 posts of 209 posts found.

Dr Mikael von Euler moves to Oncos Therapeutics

February 10, 2011
Research and Development Dr Mikael von Euler, Oncos Therapeutics, appointment, research and development

Finnish biotech company Oncos Therapeutics has appointed Dr Mikael von Euler as chief medical officer. He has more than 20 …

Shire bags senior research execs from GSK and Abbott

February 9, 2011
Research and Development Dr Lawson Macartney, Dr Mario Saltarelli, Shire, appointment, recruitment, research and development

Shire has strengthened its speciality pharmaceuticals business with the appointment of senior research executives from GlaxoSmithKline and Abbott. Dr Lawson …

Dr Matthias joins Noxxon Pharma

February 9, 2011
Research and Development Dr Matthias Baumann, Noxxon Pharma, appointment, research and development

Berlin-based biotech Noxxon Pharma has appointed Dr Matthias Baumann as chief medical officers. He joins from Focus Clinical Drug Development, …

Bertil Lindmark joins Almirall as R&D head

January 27, 2011
Research and Development Almirall, Bertil Lindmark, appointment, research and development

Almirall has appointed Bertil Lindmark as executive director of R&D following the retirement of Dr Per-Olof Andersson. Bertil joins the …

Lilly Oncology chief resigns

January 27, 2011
Research and Development, Sales and Marketing Eli Lilly, John Johnson, Lilly Oncology, appointment, lilly, research and development, sales and marketing

Lilly has an unexpected search on its hands for someone to lead its oncology business after John Johnson unexpectedly announced …

Dr Marie-Paule Richard joins AiCuris as CMO

January 26, 2011
Research and Development AiCuris, Dr Marie-Paule Richard, appointment, research and development

German clinical research company AiCuris has appointed Dr Marie-Paule Richard as chief medical officer. She has over 24 years of …

Penn Pharma appoints Wyeth’s Edward Rowland

January 20, 2011
Manufacturing and Production, Research and Development Edward Rowland, Penn Pharma, appointment, manufacturing and production, research and development

Edward Rowland has joined Wales-based pharmaceutical drug developer and manufacturer Penn Pharma as head of operational analytical services. He moves …

EMA’s Thomas Lönngren joins market access firm

January 19, 2011
Research and Development, Sales and Marketing NDA Group, Thomas Lönngren, appointment, recruitment, research and development, sales and marketing

The former head of the EMA Thomas Lönngren has taken up a post at new European regulatory and market access …

Syntaxin appoints Russell Greig chairman

January 19, 2011
Research and Development Russell Greig, appointment, research and development, syntaxin

Oxford, UK-based biotechnology company Syntaxin has appointed Dr Russell Greig as its new chairman.Russell has over 30 years experience in …

spectrum_regulatory_simon_thorn

Dr Simon Thorn joins Spectrum Regulatory Solutions

January 12, 2011
Research and Development Dr Simon Thorn, Specrum Regulatory Services, appointment, research and development

Spectrum Regulatory Solutions has appointed Dr Simon Thorn as a senior regulatory writer. He has more than 15 years experience …

Biogen Idec appoints new head of R&D

January 6, 2011
Research and Development, Sales and Marketing Biogen IDEC, Douglas Williams, Steven Holtzman, appointment, research and development, sales and marketing

Biogen Idec has a new head of research and development, appointing Douglas Williams to oversee its global operations. The position …

GSK’s Dr Anne Phillips moves to Novo Nordisk

January 4, 2011
Research and Development, Sales and Marketing Dr Anne Phillips, Novo Nordisk, apppointment, research and development, sales and marketing

Novo Nordisk has appointed Dr Anne Phillips as vice president for clinical, medical and regulatory affairs for North America. She …

Merck KGaA appoints new head of pharma

December 17, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010
Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …

Elan names Robert Ingram as new chairman

December 10, 2010
Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …

The Gateway to Local Adoption Series

Latest content